Data Sheet
GELITA® RXL technology prevents cross-linking
The GELITA Pharmaceutical Competence Team has developed a new technology: GELITA® RXL (Reduced Cross-Linking gelatine) that adds extra value to gelatine capsules. It significantly reduces cross-linking, thus enhancing the dissolution properties of the capsules as well as improving their shelf-life at high temperatures and humidity. The new technology even allows the pharmaceutical industry to explore new capsule fillings and expand their distribution into regions that are exceptionally hot and humid.
